Medlab Clinical Ltd operates in the Commercial physical research sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Medlab Clinical Ltd with three other
companies in this sector in AUSTRALIA :
Imugene Limited
(2020
sales of 4.21 million Australian Dollars [US$3.25 million]
of which 100%
was Health technologies),
Paradigm Biopharmaceuticals Ltd
(4.70 million Australian Dollars [US$3.62 million]
), and
Starpharma Holdings Limited
(7.12 million Australian Dollars [US$5.49 million]
of which 100%
was Discovery, development & commercial of D).
Sales Analysis.
During the second
fiscal
quarter of 2021, sales at Medlab Clinical Ltd totalled
A$3.97 million.
This is
an increase of 57.4%
from the A$2.52 million in sales at the company during the second quarter of 2020.
Medlab Clinical Ltd reported sales of A$5.37 million (US$4.14 million)
for the
fiscal
year ending
June of 2020.
This
represents
a
sharp
decrease of 31.1%
versus 2019, when the company's sales were A$7.80 million.
Contributing to the drop in overall sales was the 77.4% decline
in Corporate/ Other, from A$336,467.00 to A$76,142.00 .
There were also decreases in sales in
Nutraceutical (down 57.5% to A$2.16 million)
.
However, these declines were partially offset by the increase in sales of
Pharmaceutical Research (up 34.2% to A$3.58 million)
.